Dr. Douglas W. Scharre MD
Neurologist | Neurology
2050 KENNY RD FL 7 COLUMBUS OH, 43221About
I specialize in cognitive disorders and dementias, including Alzheimer's disease. The care I provide takes into account that every patient is unique. They come with different talents, varied experie ... ...
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
UrologyAmerican Board of UrologyABU- 1990
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Cognitive and behavioral effects of quetiapine in Alzheimer disease patients.
- Donepezil in the treatment of dementia with lewy bodies.
- Effects of static and radiofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging.
- Problem solving ability in patients with mild cognitive impairment.
- One-week dose titration of extended release galantamine in patients with Alzheimer's disease.
- Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues.
- Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.
- Normal pressure hydrocephalus: measure twice, shunt once.
- Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease.
- Gene expression profiling of brain samples from patients with Lewy body dementia.
- Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer's disease diagnosis and prognosis.
- HIV and acute onset of psychosis.
- Visual agnosia and optic aphasia: are they anatomically distinct?
- Parkinson's disease: making the diagnosis, selecting drug therapies.
- Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria.
Clinical Trials
- Efficacy and Safety of MMFS in Mild AD
- A Study of LY3002813 and LY3202626 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
- A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
- 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
- A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
- Escitalopram for Agitation in Alzheimer's Disease
- Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Treatments
- Neurobehavior, Alzheimer's Disease, Dementia And More
Dr. Douglas W. Scharre MD's Practice location
Dr. Douglas W. Scharre MD's reviews
Write ReviewPatient Experience with Dr. Scharre
Recommended Articles
- An Innovation in Alzheimer's That Is Still Under Used
In November 2017, Bill Gates announced his significant investment of 100 million USD to support the efforts in finding the drugs that could help to understand Alzheimer’s disease. Gates pointed out that this investment would help to fund the analysis of the massive amounts of data that has been...
- What Is Duchenne Muscular Dystrophy? Causes, Symptoms, and Treatment
Muscular dystrophies are a group of diseases that make the muscles of the body weaker over a period of time. The muscles become less flexible in this condition. Out of the nine types of muscular dystrophy, Duchenne muscular dystrophy is one of the most common.The main characteristics of this medical...
- Why Do Hallucinations Happen?
IntroductionHallucinations are sensations that people perceive as real, but in reality, are only created by their mind. A person's five senses are often affected. Examples are hearing voices without anyone around or seeing images that are not real. Such symptoms are may due to mental illnesses, drug...
- How Diet Can Ease Multiple Sclerosis Symptoms
People who live with MS look for effective approaches to enhance their quality of life. Good nutrition is a fundamental element of health promotion. In fact, maintaining a healthy and well-balanced diet offers a sense of control when coping with a disease that is considered unpredictable. Moreover,...
- Researchers Understand More About Why Brain Cells Die in Parkinson's Disease
One of the significant hurdles in finding the treatment of any of the neurodegenerative diseases is the limited knowledge regarding the underlying mechanism. It is known that Parkinson’s and many other neurodegenerative disorders occur due to the buildup of malformed proteins. In the case of...
- The Robotic Device to Improve Balance and Gait in Parkinson’s Patients
Parkinson’s disease is a neurodegenerative disorder that severely incapacitates the patient, rendering him or her unable to perform certain tasks — especially in its more advanced stages. Fortunately, when compared to other neurodegenerative disorders, such as Alzheimer’s, Parkinson’s is...
Nearby Providers
- Dr. Kristin Johnson D.O.931 Chatham Ln Columbus OH 43221
- Dr. Stephen J. Kolb MD, PHD2050 KENNY RD COLUMBUS OH 43221
- Dr. Brendan J Kelley MD2050 KENNY RD COLUMBUS OH 43221
- Dr. Erick A Arce MD931 Chatham Ln Columbus OH 43221
- Dr. Michel T Torbey MD2050 KENNY RD COLUMBUS OH 43221
- Dr. Jacquelyne Susan Cios M.D.2050 Kenny Rd Columbus OH 43221